$10 co-pay now available for Tyvaso (treprostinil) and Remodulin (treprostinil)

Having trouble viewing this e-mail? View web version

NOW AVAILABLE

Additional co-pay support for the commercially insured

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Tyvaso and Remodulin are now part of the
United Therapeutics co-pay assistance program

Under this co-pay assistance program, eligible
patients who enroll may pay only $10 per co-pay
for each medication, up to a $6000 savings per year.

. . . . . . . . . . . . . . . . . . . . . . . .

For more information, you or your patients can

Visit www.UTcopay.com or
call 1-800-246-5307
for Tyvaso and Remodulin

Call ASSIST
1-877-864-8437
for Orenitram

To learn more, contact your

United Therapeutics sales representative

TO ENROLL IN THIS PROGRAM, YOUR PATIENTS MUST UNDERSTAND AND AGREE TO COMPLY WITH THE ELIGIBILITY REQUIREMENTS AND TERMS OF USE.

Eligibility Requirements for this program are:

•	Patients must be 18 years or older to use this Program
•	The Program is valid only for patients with commercial (also known as private) insurance who are taking the medication for an FDA-approved indication
•	Patients using Medicare, Medicaid, or any other state or federal government program to pay for their medications are not eligible. Patients who start utilizing government coverage during the term of the Program will no longer be eligible
•	Eligible patients must be residents of the US or Puerto Rico

Visit www.UTcopay.com for full program details and Terms and Conditions.

Unither.com |

This promotional communication is provided by United Therapeutics.

This message was sent to [email]. If you do not wish to receive e-mails
from United Therapeutics, please click here.

Please do not reply to this e-mail, as this is an unattended e-mail box.

Orenitram, Remodulin, and Tyvaso are registered trademarks of United Therapeutics Corporation.